A Framework for Enhancing the Value of Research for Dissemination and Implementation

Gila Neta1, Russell E Glasgow, Christopher R Carpenter

  • 1Gila Neta is with Implementation Science, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, MD. Russell E. Glasgow is with Department of Family Medicine and Colorado Health Outcomes Research Program University of Colorado, Denver. Christopher R. Carpenter is with Washington University School of Medicine, Division of Emergency Medicine, St Louis, MO. Jeremy M. Grimshaw is with Clinical Epidemiology Program, Ottawa Hospital Research Institute, and Department of Medicine, University of Ottawa, Ontario. Borsika A. Rabin is with Department of Family Medicine, School of Medicine, University of Colorado, and CRN Cancer Communication Research Center, Institute for Health Research, Kaiser Permanente Colorado, Denver. Maria E. Fernandez is with Center for Health Promotion and Prevention Research, School of Public Health, University of Texas Health Science Center at Houston. Ross C. Brownson is with Prevention Research Center in St Louis, Brown School, Washington University in St Louis, and Division of Public Health Sciences, and Alvin J. Siteman Cancer Center, Washington University School of Medicine.

Summary

Researchers need better ways to report on dissemination and implementation research. A new framework emphasizes transparent reporting across all research phases to improve the value of findings for practitioners and decision-makers.

Related Concept Videos

Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
26.3K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
338
Nursing Implementation01:15

Nursing Implementation

Implementation is the execution of the nursing care plan developed during the planning phase.
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
6.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
587
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
574
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
582